Close menu




September 11th, 2025 | 07:15 CEST

The Hidden Champions of 2025: Puma, Sranan Gold and AMD – Where it might be worth getting in

  • Mining
  • Gold
  • Software
  • AI
  • chips
  • Sportswear
Photo credits: pixabay.com

As an investor, it is often wise to find hidden gems rather than buy expensive market leaders. While large corporations are often overvalued, undervalued small caps offer unique opportunities. Whether as turnaround candidates, commodity gems, or technology leaders, these specialized companies have the potential to dominate their niches and initiate a quiet catch-up rally. For savvy investors, this second tier is the real source of above-average returns. Three promising candidates that embody this profile are sporting goods manufacturer Puma, gold explorer Sranan Gold, and chip designer AMD. Let's take a look at their current situation.

time to read: 4 minutes | Author: Armin Schulz
ISIN: PUMA SE | DE0006969603 , SRANAN GOLD CORP | CA85238C1086 , ADVANCED MIC.DEV. DL-_01 | US0079031078

Table of contents:


    Puma – The rocky road back to the top

    The current situation at Puma is challenging. The second quarter brought a currency-adjusted decline in revenue and an operating loss. This was driven by weak demand in core markets such as North America and China, lower margins, and the burden of US special tariffs. As a result, the management board has drastically lowered its forecast for 2025 and now expects an operating loss. The stock market has already punished this development.

    But this is precisely where the opportunity for a turnaround lies. Management is not sitting idly by. Under new CEO Arthur Hoeld, a rigorous efficiency program is being implemented that cuts investments and reduces inventories to preserve liquidity. At the same time, the strategy is being realigned. High-margin direct sales are being promoted in order to become less dependent on the turbulent wholesale market. This "reset year" is intended to lay the foundation for more sustainable growth from 2026 onwards.

    Analysts remain divided. While some are downgrading the stock due to its short-term weakness, others recognize the long-term potential of the realignment. The latest news that major shareholder Artemis considers its 29% stake to be "non-strategic" and is reviewing all options is also fueling speculation about a possible change of ownership. These takeover hopes could quickly have a positive effect on the share price. The majority of analysts advise patience. The turnaround depends on whether the new strategic levers can be consistently leveraged. The stock is currently trading at EUR 19.22.

    Sranan Gold - Exploration successes underscore potential in Suriname

    Sranan Gold is advancing the exploration of its Tapanahony project in Suriname at a noticeable pace. The property lies within the mineral-rich Guiana Shield, a well-established mining region supported by a stable legal framework based on Dutch law. Recent results from the ongoing trenching program provide further evidence of the potential extent of mineralization. A 5 m section averaging 8.9 g/t gold underscores the continuity of the corridor known as the "Randy Trend." Peak values of 18.78 g/t were found. These values confirm earlier findings announced on August 7, when a sample returned 36.7 g/t gold just 150 m south of Randy's Pit.

    This near-surface work, which is being conducted in parallel with a diamond drilling program, aims to systematically map the mineralized zone and prepare it for future resource estimates. The geological signature confirms the complexity of the system. The mineralization occurs in northeast-trending, sheared felsic rocks, a structure often associated with high-grade gold deposits in the region. The similarity to neighboring zones, where values of up to 57 g/t have already been documented, is a strong indication of the scalable potential of the entire trend. Methodically advancing this systematic expansion of known zones through trenching and drilling is a sign of professional exploration.

    Another significant step was the recent submission of an independent technical report in accordance with NI 43-101. This document forms the crucial basis for the evaluation and further development of the 29,000 ha project. This creates transparency and reliability for investors. The Company also has a solid liquidity position to carry out the 10,000 m drilling program without immediate financing pressure, thereby continuously generating value appreciation. The stock has not recently benefited from the gold discoveries and is currently trading at CAD 0.46.

    AMD – Why the AI underdog could shine in the shadow of Nvidia

    While Nvidia dominates the headlines, AMD often stands as the second-best player away from the spotlight. But this perception could distort the bigger picture. Analysts increasingly believe that the AI market is divided into two phases: training and inference. While Nvidia clearly dominates model training, the far greater opportunity lies in operational use, or inference. This is where AMD could score with its more cost-efficient and specialized chips, as executing already trained models requires less computing power but more efficiency.

    Another often overlooked point is software. Although Nvidia has set a powerful standard with CUDA, AMD's open-source platform ROCm is gaining momentum. ROCm is increasingly being used, especially by hyperscalers such as Microsoft and Meta, which have huge engineering teams. Their interest is clear: they do not want to be dependent on a single provider. This strategic push by the tech giants could give AMD the boost it needs to establish itself as a serious alternative.

    Despite a high price-to-earnings ratio, many do not consider AMD to be overpriced, but rather undervalued in terms of growth potential. The expectation is that the inference market will explode, and AMD, with its hardware and software strategy, is perfectly positioned to benefit. If the Company captures even a small portion of the AI market dominated by Nvidia, the current valuations would be more than justified. The key lies in expanding profitability by shifting toward AI products with higher margins. The stock is currently trading at around USD 161.


    For investors willing to question established narratives, these hidden champions offer a fascinating risk-reward profile. Puma is tackling its challenging turnaround with a rigorous efficiency program and strategic realignment. Sranan Gold is underpinning the scalable potential of its gold project in Suriname through systematic exploration and excellent discoveries. AMD is skillfully positioning itself as a cost-efficient alternative in the AI inference market, fueled by the open-source ROCm software strategy embraced by tech giants. Diversifying across these three promising niches could pay off.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Armin Schulz

    Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.

    About the author



    Related comments:

    Commented by André Will-Laudien on October 2nd, 2025 | 07:25 CEST

    AI fuels cancer research: Bayer, Vidac Pharma, and Pfizer are the next 150% winners

    • AI
    • Biotechnology
    • Biotech
    • Pharma

    The stock market remains strong! In addition to the tech and defense boom, the biotech sector has also been catching up in recent days, with the latest news in cancer research bringing the industry back into the spotlight. The key factor here is artificial intelligence, which is revolutionizing cancer research through personalized therapy approaches based on the evaluation of extensive clinical and genetic data. AI models make it possible to predict individual cancer progression better and tailor therapies to individual patients. By analyzing multimodal data, AI systems can more accurately assess the risk of metastasis and thus develop targeted treatment strategies. AI has also improved tumor diagnostics by accurately detecting numerous types of cancer, therefore ensuring a more precise diagnosis.

    Read

    Commented by Nico Popp on October 2nd, 2025 | 07:15 CEST

    Graphite problem solvers with small valuation: SGL Carbon, Mercedes-Benz, Graphano Energy

    • Mining
    • graphite
    • Electromobility
    • Batteries

    Battery-grade graphite is classified as a critical element in both the US and the EU. The reason: supply chains have been too dependent on China. Recent geopolitical shifts have caused decision-makers on both sides of the Atlantic to rethink their approach to graphite and other critical raw materials. Secure sources are now in high demand. At the same time, sustainability and environmental protection remain key requirements for projects. In this article, we explain the latest developments in the graphite market and how investors can benefit from them.

    Read

    Commented by Carsten Mainitz on October 2nd, 2025 | 07:10 CEST

    NetraMark Holdings, Evotec, Sartorius – Billion-dollar deals in sight!

    • Biotechnology
    • Biotech
    • AI
    • Pharma

    Artificial intelligence and machine learning have become key drivers across nearly every industry. When pharmaceutical companies successfully develop a drug to market readiness, profits can surge. However, only a few active ingredients that enter clinical trials ultimately receive approval. It is therefore a long, risky, and costly process. The use of AI can help to minimize these risks significantly. Here, we take a look at the potential of AI-based strategies among established players Evotec and Sartorius, with a particular focus on the innovative approach of Canadian company NetraMark Holdings.

    Read